PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Other Non-Current Liabilities (2020 - 2025)

PRF Technologies' (PRFX) quarterly Other Non-Current Liabilities came in at $267000.0 in Q4 2025, up 3.09% on a YoY basis from $259000.0 in Q4 2024, and up 1.52% quarter-over-quarter from $263000.0 in Q2 2025.

Analysis

PRF Technologies (PRFX) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Other Non-Current Liabilities for 6 consecutive years, with $267000.0 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Liabilities rose 3.09% year-over-year to $267000.0; the trailing twelve-month figure through Dec 2025 stood at $267000.0 (up 3.09% YoY), and the FY2025 full-year result was $267000.0, up 3.09% from the prior year.
  • Other Non-Current Liabilities climbed to $267000.0 in Q4 2025 per PRFX's latest filing, from $263000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $863000.0 in Q3 2023 and bottomed at $220000.0 in Q2 2021.
  • Historically, Other Non-Current Liabilities has averaged $303636.4 across 5 years, with a median of $251000.0 in 2023.
  • The sharpest annual moves came in 2021 and 2022: Other Non-Current Liabilities slumped 85.45% in 2021, then advanced 8.18% in 2022.
  • Over 5 years, Other Non-Current Liabilities stood at $234000.0 in 2021, then grew by 3.85% to $243000.0 in 2022, then grew by 3.29% to $251000.0 in 2023, then gained by 3.19% to $259000.0 in 2024, then climbed by 3.09% to $267000.0 in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $267000.0, $263000.0, and $259000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn
10 PRF Technologies 622,054.07 -10.31 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 267,000.00
Jun 30, 2025 263,000.00
Dec 31, 2024 259,000.00
Jun 30, 2024 255,000.00
Dec 31, 2023 251,000.00
Sep 30, 2023 863,000.00
Jun 30, 2023 247,000.00
Dec 31, 2022 243,000.00
Jun 30, 2022 238,000.00
Dec 31, 2021 234,000.00
Jun 30, 2021 220,000.00
Dec 31, 2020 220,000.00
Sep 30, 2020 1.07 Mn
Jun 30, 2020 1.51 Mn
Mar 31, 2020 802,000.00
API Access

PRF Technologies Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PRFX&period=max&api_key=YOUR_API_KEY